Blog Posts - Myrexis

(RGEN, PWRM, MYRX, CRWE, FCAL) Stock Report from

Repligen Corporation (NASDAQ:RGEN) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for RG3039, a potential treatment for Spinal Muscular Atrophy (SMA). Fast Track is a process designed to facilitate the d...

(AVOT, VVTV, HSWI, MYRX) Stocks in Review by Stock Report from Wall Street

American Video Teleconferencing Corp (AVOT) Rare-earth metals are the key to 21st Century technology: Without them, we wouldn’t have smart phones, hybrid cars or precision weapons. And China, which mines most of the world’s rare-earth met...

Trending Topics